Synapse - David Straus

Results (361)

Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease

Journal Article

Hirsch, A.; Vander Els, N.; Straus, D. J.; Gomez, E. G.; Leung, D.; Portlock, C. S.; Yahalom, J.
Journal of Clinical Oncology (1996)

Fulltext@MSK | Save

CD30 (Ki-1)-positive malignant lymphomas: Clinical, immunophenotypic, histologie, and genetic characteristics and differences with Hodgkin's disease

Journal Article

Filippa, D. A.; Ladanyi, M.; Wollner, N.; Straus, D. J.; O'Brien, J. P.; Portlock, C.; Gangi, M.; Sun, M.
Blood (1996)

Fulltext@MSK | Save

Initial clinical study of a selective retinoid "X" receptor (RXR) agonist

Meeting Abstract

Miller, V. A.; Benedetti, F. M.; Rigas, J. R.; Tong, W. P.; Kris, M. G.; Gill, G. M.; Truglia, J. A.; Ulm, E.; Straus, D.; Warrell, R. P. Jr
Proceedings of the American Association for Cancer Research Annual Meeting (1995)

Fulltext@MSK | Save

Autologous bone marrow transplantation following high-dose chemotherapy with or without accelerated hyperfractionated total lymphoid irradiation for patients with refractory or relapsed Hodgkin's disease

Meeting Abstract

Moni, J.; Yahalom, J.; Bertino, J.; O'Brien, J.; Portlock, C.; Straus, D.; Zelenetz, A.; Gomez, E.; Gulati, S.
International Journal of Radiation Oncology, Biology, Physics (1995)

Fulltext@MSK | Save

Initial dose-intense therapy with vincristine (V), adriamycin (A) and dexamethasone (D) followed by high-dose cyclophosphamide (CY), results in high remission rates in patients with advanced myeloma (MM) with poor prognostic features

Meeting Abstract

Niesvizky, R.; Choy, C. G.; Siegel, D.; Straus, D.; Myers, J. E.; Heller, G.; Michaeli, J.
Blood (1995)

Fulltext@MSK | Save

High-risk Hodgkin's disease prognostic factors

Conference Paper

Straus, D. J.
Taylor & Francis Group (1995)

Fulltext@MSK | Save

The effect of ABVD chemotherapy with and without mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease

Meeting Abstract

Hirsch, A.; Vander Els, N.; Gomez, E. G.; Leung, D.; Portlock, C. S.; Straus, D. J.; Yahalom, J.
International Journal of Radiation Oncology, Biology, Physics (1994)

Fulltext@MSK | Save

A dose-intensive program of cyclophosphamide (C) with G-CSF after vincristine (V), adriamycin (a) and dexamethasone (D) induction for patients with advanced multiple myeloma (MM)